Why Atai Life Sciences Stock Crushed It on Tuesday Investors cheered good news from the lab delivered by the company.
Atai Life Sciences Experimental Depression Drug Shows Sustained Benefit In Treatment-Resistant Patients Atai Life Sciences and Beckley Psytech report strong BPL-003 study results in treatment-resistant depression, with Phase 3 trials expected in 2026.
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225% On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (
NASDAQ:TEM ) and buying shares of Brera Holdings PLC (
NASDAQ:BREA ),
Why Is ATAI Life Sciences Stock Trading Lower On Monday? Recognify's CIAS trial for inidascamine missed its main endpoint but showed positive signals in cognitive domains and had a favorable safety profile.
What's going on in today's pre-market session Discover the top movers in Monday's pre-market session and stay informed about market dynamics.
US Stocks Likely To Open Higher As US-EU Ink Trade Deal: Tesla, Palantir, UnitedHealth In Focus U.S. stock futures rose on Monday after ending higher on Friday. Futures of major benchmark indices were higher.
Top movers in Friday's after hours session Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
Which stocks are experiencing notable movement on Tuesday? Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Let's uncover which stocks are experiencing notable gaps during today's session. Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Atai Life Sciences And Merger Partner Set Up Psychedelic Depression Therapy With Encouraging Late-Stage Data Atai and Beckley report that a single dose of BPL-003 reduced depression symptoms significantly and safely in treatment-resistant patients.
Get insights into the top gainers and losers of Tuesday's pre-market session. Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors Psychedelics litigator Matthew Zorn joins HHS under RFK Jr. to lead policy. What it means for CMPS, MNMD, CYBN, PSIL & more.
